C9orf135

Jump to navigation Jump to search
VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

C9orf135 is a gene that encodes a 229 amino acid protein. It is located on Chromosome 9 of the Homo sapiens genome at 9q12.21.[1] The protein has a transmembrane domain from amino acids 124-140 and a glycosylation site at amino acid 75. C9orf135 is part of the GRCh37 gene on Chromosome 9 and is contained within the domain of unknown function superfamily 4572.[2] Also, c9orf135 is known by the name of LOC138255 which is a description of the gene location on Chromosome 9.1.[3]

File:C9orf135 Gene Location.gif
c9orf135 location on chromosome 9 and the neighboring genes.

There is some evidence associating the c9orf135 gene with premature ovarian failure.[4] In affected women, an autosomal recessive microduplication occurs which may be linked to premature ovarian failure. A Single Nucleotide Polymorphism (SNP) the c9orf135 gene has been linked to Parkinson’s disease; a statistically significant mutation has been seen on a Manhattan plot.[5] Further research is required to establish whether c9orf135 relates to Parkinson’s disease.[5]

mRNA

File:Slice variants.png
Splice Variants of c9orf135 based on NCBI AceView

The mRNA of c9orf135 is 906 nucleotides in length.[6] The 5' and 3' Untranslated regions (UTR) contain hairpin loops[7]. The 3' UTR comprises 123 nucleotides and the 5' UTR comprises 18 nucleotides. The mRNA encodes a protein with a secondary structure composed of both beta-sheets and alpha-helices.[8]

Protein

Properties of c9orf135

It is likely that c9orf135 is a nuclear protein because it has properties that match attributes of nuclear proteins rather than secretory pathways.[9][10] Furthermore, there is a nuclear localization signal (PEKVKKL) from amino acid 67 to 73 on c9orf135.[11] C9orf135 is soluble with an average hydrophobicity of -0.772. The negative hydrophobicity value is due to its slightly acidic properties.[12]

Post-translational modifications

Serine phosphorylation sites were seen at amino acid positions 7, 50, 86, 98, and 194. Threonine phosphorylation occurs at 34, 129, 155, and 201. Tyrosine phosphorylation sites occur at 78, 160, 177, and 209. Also, a N-terminal acetylation site is present at amino acid 3. A Signal cleavage site is present between amino acids 11 and 12.[13]

Protein Interaction

PB2 interacts with c9orf135 which was found from a two-hybrid yeast assay. The information provided about PB2 (Polymerase Basic Protein 2) is that it is a viral protein that is involved with the influenza A virus. It is primarily involved in Cap stealing in which it binds the pre-mRNA cap an ultimately cleaves 10-13 nucleotides off. PB2 is also important for starting the replication of viral genomes. PB2 is also known to inhibit type 1 interferon by inhibiting the mitochondrial antiviral signalling protein MAVS.[14]

Mutations

Eleven different common DNA genome variants of the human c9orf135 gene have been identified. All of the mutations within those genome variants have been compiled into the following table.[15] Mutations that were present at levels of 0.01 frequency or higher have been incorporated into the table; synonymous mutations were excluded.

Location Amino Acid Position Mutation Frequency
5' UTR 57 N/A 0.386
5' UTR 93 N/A 0.047
5' UTR 138 N/A 0.018
Exon 169 Missense K30T 0.018
Exon 237 Missense R53K 0.047
Exon 456 Missense E126K 0.01

Gene Expression

c9orf135 is expressed in connective tissue and testicular tissue at high levels.[16] It is likely that the expression of c9orf135 is expressed at low levels throughout human cells. It was also found that c9orf135 is found at significantly higher levels in the adult human umbilical cord versus the foetal human umbilical cord.[17] Furthermore, in women with ovarian adenocarcinoma the expression of c9orf135 is much higher in the epithelial cells within the ovaries.[18] Women with polycystic ovarian syndrome have a lower expression of c9orf135 than those people who do not have the condition.[19]

Amino Acid Quantity

A comparison between the c9orf135 from Mus musculus (House Mouse) and Pteropus alecto (Black Flying Fox) is described here. There were no significant amino acids that differed in c9orf135 from the rest of the mouse body. However, in the Black Flying Fox, it was valine poor and tryptophan rich. As seen from the human results, the Black Flying fox only shared the tryptophan surplus results. The House Mouse and Black Flying Fox were both used because they shared 64% and 79% similarity in the c9orf135 genome respectively. Analysis demonstrates that alanine and tyrosine could predict points of interest because they both contained results differing from the rest of the human gene averages.[12]

Amino Acid of Interest Compositional Percentage

Compared to normal protein amounts in H. sapiens

Alanine 3.1% Less than Average
Tyrosine 5.2% More than Average
Trytophan 3.1% More than average

Homology

c9orf135 is conserved through eukaryotes, ranging from mammals, reptiles and Annelida.

Orthologs

The orthologs of c9orf135 were sequenced in BLAST and 20 orthologs were picked. The orthologs were all multicellular organisms and were limited to aquatic animals, reptiles, amphibians, and warm-blooded animals. Also, protists, bacteria, archea, and fungi did not have orthologs. However, no paralogs were found when c9orf135 was sequenced in BLAST. Please refer to the spreadsheet for the complete list of orthologs to c9orf135. Time tree was a program that was used to find the evolutionary branching shown in MYA[20] There were no paralogs found for c9orf135.

Genus/Species Common name Divergence from Humans (MYA) Accession number Amino Acid Length Sequence identity Sequence similarity
Homo sapiens Human -- Q5VTT2 229 -- --
Pongo abelii Sumatran Orangutan 15.8 XP_002819904 206 86% 87%
Rhinopithecus roxellana Golden Snub-Nosed Monkey 29.1 XP_010361250 229 93% 95%
Mus musculus House Mouse 90.9 EDL41604 228 64% 73%
Pteropus alecto Black Flying Fox 97.5 XP_785964 230 79% 86%
Equus przewalskii Przewalski's horse 97.5 XP_008504806 183 77% 86%
Panthera tigris altaica Siberian Tiger 97.5 XP_007077537 187 73% 83%
Ovis aries Sheep 97.5 XP_014948670 207 69% 77%
Elephantulus edwardii Cape Elephant Shrew 105 XP_006894485 254 72% 82%
Pelodiscus sinensis Chinese Softshell Turtle 320.5 XP_006137902 217 55% 68%
Gekko japonicus Gekko 320.5 XP_015275999 221 52% 64%
Alligator mississippiensis American Alligator 320.5 XP_014464144 212 51% 64%
Ophiophagus hannah King Cobra 320.5 ETE61720 215 43% 59%
Salmo Salar Atlantic Salmon 429.6 XP_013998840 99 34% 55%
Esox lucius Northern Pike 429.6 XP_010901691 154 30% 47%
Branchiostoma floridae Lancelet 733 XP_002591786 221 45% 59%
Strongylocentrotus purpuratus Sea Urchin 747.8 XP_785964 241 47% 62%
Saccoglossus kowalevskii Acorn Worm 747.8 XP_002733410 153 38% 58%
Lingula anatina Ocean Clam 847 XP_013398605 220 43% 59%
Crassostrea gigas Pacific Oyster 847 XP_011426944 215 40% 57%
Helobdella robusta Leech 847 XP_009019861 256 29% 44%

Divergence of c9orf135

A divergence comparison of c9orf135 with fast diverging cytochrome C, and slow diverging fibrinogen is shown in the chart. Overall, c9orf135 has diverged significantly quicker than fibrinogen and slightly slower than cytochrome C.

File:C9orf135 Divergence.png

References

  1. NCBI, Protein, https://www.ncbi.nlm.nih.gov/protein/Q5VTT2.1
  2. BLAST protein sequence, c9orf135, http://blast.ncbi.nlm.nih.gov/Blast.cgi
  3. Result Filters. (n.d.). Retrieved February 07, 2016, from https://www.ncbi.nlm.nih.gov/protein/Q5VTT2.1
  4. Genomic analysis using high-resolution single-nucleotide polymorphism arrays reveals novel microdeletions associated with premature ovarian failure. McGuire, Megan M; Bowden, Wayne; Engel, Natalie J; Ahn, Hyo Won; Kovanci, Ertug et al.(2011) Fertility and sterility vol.95(5)p.1595-600
  5. 5.0 5.1 Genomic determinants of motor and cognitive outcomes in Parkinson's disease. Chung, Sun Ju; Armasu, Sebastian M; Biernacka, Joanna M; Anderson, Kari J; Lesnick, Timothy G et al.(2012)Parkinsonism & related disorders vol. 18(7)p.881-6
  6. NCBI, Nucleotide, https://www.ncbi.nlm.nih.gov/nuccore/809279636?report=fasta
  7. Sfold, Srna, http://sfold.wadsworth.org/cgi-bin/showcentroid.pl
  8. I-Tasser, http://zhanglab.ccmb.med.umich.edu/I-TASSER/
  9. YLoc http://abi.inf.uni-tuebingen.de/Services/YLoc/webloc.cgi?id=86ac5008fd25bd20a065f49a970fd19c
  10. SOSUI Classification and Secondary Structure Prediction of Membrane Proteins, http://harrier.nagahama-i-bio.ac.jp/sosui/
  11. PSORT II, PSORT II Prediction, http://psort.hgc.jp/cgi-bin/runpsort.pl[permanent dead link]
  12. 12.0 12.1 SDSC Biology Workbench, SAPS, http://seqtool.sdsc.edu/CGI/BW.cgi#[permanent dead link]!
  13. ExPasy, Sibs bioinformatics analysis, http://www.expasy.org/
  14. "1 binary interaction found for search term C9orf135". IntAct Molecular Interaction Database. EMBL-EBI. Retrieved 2018-08-25.
  15. NCBI SNP Geneview https://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?geneId=138255&ctg=NT_008470.20&mrna=XM_011518232.1&prot=XP_011516534.1&orien=forward
  16. EST profile, NCBI, https://www.ncbi.nlm.nih.gov/nuccore/NM_001308086.1
  17. Geo Profile, NCBI https://www.ncbi.nlm.nih.gov/geoprofiles/78193260
  18. Geo Profile, Ovarian normal surface epithelia and the ovarian cancer epithelial cells, https://www.ncbi.nlm.nih.gov/geo/tools/profileGraph.cgi?ID=GDS3592:236519_at
  19. Geo Profile, Obese women with polycystic ovary syndrome and obese, healthy women: skeletal muscle, https://www.ncbi.nlm.nih.gov/geo/tools/profileGraph.cgi?ID=GDS4133:243610_at
  20. Hedges SB, Marin J, Suleski M, Paymer M & Kumar S (2015) Tree of Life Reveals Clock-Like Speciation and Diversification. Mol Biol Evol 32: 835-845

Further reading

Chromosome 9